Diagnostic criteria and classification of mastocytosis: a consensus proposalPeter Valent, John M. Bennett, Hans‐P. Horny et al.|Leukemia Research|2001Cited by 1.1k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Peter Valent, Rupal O’Quinn et al.|European Heart Journal|2021Cited by 589
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CMLGeorg E. Winter, Giulio Superti‐Furga, Uwe Rix et al.|Nature Chemical Biology|2012Cited by 96
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Peter Valent, Massimiliano Bonifacio et al.|Leukemia|2021Cited by 55
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligandViviane Ghanim, Peter Valent|Blood|2012Cited by 38